# Fludeoxyglucose F 18

NDC: 49609-101
Generic name: Fludeoxyglucose F-18
Labeler / Manufacturer: SOFIE Co.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20111208

FDA application: ANDA203591

## Active ingredients

- FLUDEOXYGLUCOSE F-18: 300 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"49609-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49609-101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2028be0c-333c-4e0c-be57-099276c725d7